Number of the records: 1
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis
- 1.PETERS, D. E., NORRIS, L. D., TENORA, L., ŠNAJDR, I., PONTI, A. K., ZHU, X., SAKAMOTO, S., VEERAVALLI, V., PRADHAN, M., ALT, J., THOMAS, A. G., MAJER, P., RAIS, R., MCDONALD, C., SLUSHER, B. S. A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491. ISSN 1946-6234. E-ISSN 1946-6242. Available: doi: 10.1126/scitranslmed.abn7491.
Number of the records: 1